Suppr超能文献

腮腺涎腺癌。

Salivary duct carcinoma of the parotid.

机构信息

Service de Chirurgie Cervicofaciale, Hôpital du Val-de-Grâce, 74, boulevard de Port-Royal, 75230 Paris cedex 05, France.

出版信息

Eur Ann Otorhinolaryngol Head Neck Dis. 2011 Sep;128(4):194-6. doi: 10.1016/j.anorl.2010.12.008. Epub 2011 Apr 6.

Abstract

INTRODUCTION

Salivary duct carcinoma is one of the rarest and most aggressive forms of parotid tumor. We report two cases.

CASES

Case 1: a 78-year-old man was referred for a salivary duct carcinoma of the left parotid gland. Treatment was surgical (parotidectomy with ipsilateral selective neck dissection), without capsule rupture, and with healthy margins. At seven years' follow-up, the patient was alive and disease-free. Case 2: a 41-year-old man was referred for a salivary duct carcinoma of the left parotid gland. Parotidectomy with ipsilateral selective neck dissection left healthy but insufficient margins (<1 cm), and postoperative radiation therapy (70 Gy) was undertaken. At eight years' follow-up, the patient was alive and free of recurrence.

DISCUSSION

Mean patient age in the literature is 60 years, with a male-to-female ratio of 2:1. Mean five-years' recurrence-free survival was 34%.

CONCLUSION

Surgery is the main form of treatment in this indication. Postoperative radiation therapy is indicated in case of extraparotid extension, pathological resection margins, cervical lymph node metastasis, lymphatic embolus and/or neurologic invasion. Chemotherapy is generally reserved for metastatic forms of the disease.

摘要

简介

涎腺导管癌是最罕见和最具侵袭性的腮腺肿瘤之一。我们报告两例病例。

病例 1:一名 78 岁男性因左侧腮腺涎腺导管癌就诊。治疗采用手术(腮腺切除术伴同侧选择性颈部淋巴结清扫术),无包膜破裂,切缘健康。随访 7 年时,患者存活且无疾病。

病例 2:一名 41 岁男性因左侧腮腺涎腺导管癌就诊。行腮腺切除术伴同侧选择性颈部淋巴结清扫术,切缘虽健康但不足 1cm,术后接受了放射治疗(70Gy)。随访 8 年时,患者存活且无复发。

讨论

文献中的平均患者年龄为 60 岁,男女比例为 2:1。平均 5 年无复发生存率为 34%。

结论

手术是该适应证的主要治疗形式。对于腮腺外侵犯、病理切缘、颈部淋巴结转移、淋巴管栓子和/或神经侵犯,术后放射治疗是指征。化疗通常保留用于转移性疾病形式。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验